Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial

详细信息    查看全文

• 作者：Anna P. Ralph ; Clancy Read ; Vanessa Johnston ; Jessica L. de Dassel…
• 关键词：Acute rheumatic fever ; Rheumatic heart disease ; Continuous quality improvement ; Health ; systems research ; Stepped ; wedge design
• 刊名：Trials
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：17
• 期：1
• 全文大小：1,856 KB
• 参考文献：1.Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts. Cardiovascular disease series. Cat. no. CVD 53. Canberra: AIHW. 2011. http://​www.​aihw.​gov.​au/​WorkArea/​DownloadAsset.​aspx?​id=​10737418530 . Accessed 20 Jan 2016
  2.RHDAustralia (ARF/RHD writing group). The Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd ed). National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. 2012. http://​www.​rhdaustralia.​org.​au/​sites/​default/​files/​guideline_​0.​pdf . Accessed 20 Jan 2016
  3.Ralph AP, Carapetis JR. Group A streptococcal diseases and their global burden. Curr Top Microbiol Immunol. 2013;368:1–27.PubMed
  4.RHD Australia. iPhone and Android apps. 2015. http://​www.​rhdaustralia.​org.​au/​apps . Accessed 20 Jan 2016
  5.Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia 1997–2010. Circulation. 2013;128(5):492–501.CrossRef PubMed
  6.Michaud C, Rammohan R, Narula J. Cost-effectiveness analysis of intervention strategies for reduction of the burden of rheumatic heart disease. In: Narula JVR, Reddy KS, Tandon R, editors. Rheumatic fever. Washington, D.C: American Registry of Pathology; 1999.
  7.Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002;3:CD002227.PubMed
  8.Padmavati S, Sharma KB, Jayaram O. Epidemiology and prophylaxis of rheumatic fever in Delhi − a five year follow-up. Singapore Med J. 1973;14:457–61.PubMed
  9.WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, Geneva, 29 October −1 November 2001. WHO Technical Report Series 923. Geneva: World Health Organization; 2004.
  10.McDonald M, Brown A, Noonan JR, Carapetis J. Preventing recurrent rheumatic fever: the role of register based programmes. Heart. 2005;91:1131–3.PubMedCentral CrossRef PubMed
  11.Ralph AP, Fittock M, Schultz R, Thompson D, Dowden M, Clemens T, et al. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach. BMC Health Services Res. 2013;13:525. doi: 10.​1186/​1472-6963-13-525 .
  12.Humphery K, Weeramanthri T, Fitz J. Forgetting compliance: Aboriginal health and medical culture. Darwin: Northern Territory University Press in association with the Cooperative Research Centre for Aboriginal and Tropical Health; 2001.
  13.World Health Organization. Adherence to long-term therapies: evidence for action. Noncommunicable diseases and mental health adherence to long-term therapies project. Geneva: World Health Organization; 2003.
  14.Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust. 2006;184:514–7.PubMed
  15.Mincham CM, Toussaint S, Mak DB, Plant AJ. Patient views on the management of rheumatic fever and rheumatic heart disease in the Kimberley: a qualitative study. Aust J Rural Health. 2003;11:260–5.CrossRef PubMed
  16.Davidson PM, Abbott P, Davison J, Digiacomo M. Improving medication uptake in Aboriginal and Torres Strait Islander peoples. Heart Lung Circ. 2010;19:372–7.CrossRef PubMed
  17.Hoy WE, Kondalsamy-Chennakesavan SN, Nicol JL. Clinical outcomes associated with changes in a chronic disease treatment program in an Australian Aboriginal community. Med J Aust. 2005;183(6):305–9.PubMed
  18.Su J-Y, Skov S. An assessment of the effectiveness of the Tiwi Sexual Health Program 2002–2005. Aust N Z J Public Health. 2008;32(6):554–8.CrossRef PubMed
  19.Haynes RB, Ackloo E, Sahota N. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.PubMed
  20.Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20:64–78.CrossRef
  21.Northern Territory Government Department of Health. The Northern Territory chronic conditions self management framework 2012–2020. Darwin. 2012. http://​digitallibrary.​health.​nt.​gov.​au/​prodjspui/​bitstream/​10137/​551/​5/​CCSM2012-2020.​pdf . Accessed 20 Jan 2016
  22.Bailie RS, Si D, O'Donoghue L, Dowden M. Indigenous health: effective and sustainable health services through continuous quality improvement. Med J Aust. 2007;186:525–7.PubMed
  23.Bailie R, Si D, Dowden M, O'Donoghue L, Connors C, Robinson G, et al. Improving organisational systems for diabetes care in Australian Indigenous communities. BMC Health Serv Res. 2007;7:67.PubMedCentral CrossRef PubMed
  24.Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med. 1973;289:331–5.CrossRef PubMed
  25.Bach JF, Chalons S, Forier E, Elana G, Jouanelle J, Kayemba S, et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet. 1996;347:644–8.CrossRef PubMed
  26.Nordet P, Lopez R, Duenas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002). Cardiovasc J Afr. 2008;19:135–40.PubMedCentral PubMed
  27.One21seventy National Centre for Quality Improvement in Indigenous Primary Health Care website. http://​www.​one21seventy.​org.​au/​ . Accessed 20 Jan 2016
  28.Burgess CP, Sinclair G, Ramjan M, Coffey PJ, Connors CM, Katekar LV. Strengthening cardiovascular disease prevention in remote indigenous communities in Australia’s Northern Territory. Heart Lung Circ. 2015;24(5):450–7. doi:10.​1016/​j.​hlc.​2014.​11.​008 .CrossRef PubMed
  29.Copas AJ, Lewis JJ, Thompson JA, Davey C, Baio G, Hargreaves JR. Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches. Trials. 2015;16:352.PubMedCentral CrossRef PubMed
  30.Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6:54.PubMedCentral CrossRef PubMed
  31.Oakley A, Strange V, Bonell C, Allen E, Stephenson J, RIPPLE Study Team. Process evaluation in randomised controlled trials of complex interventions. BMJ. 2006;332:413–6.PubMedCentral CrossRef PubMed
  32.Wolff N. Randomised trials of socially complex interventions: promise or peril? J Health Serv Res Policy. 2001;6:123–6.CrossRef PubMed
  33.Hawe P, Shiell A, Riley T. Complex interventions: how ‘out of control’ can a randomised controlled trial be? BMJ. 2004;328:1561–3.PubMedCentral CrossRef PubMed
  34.Chen H-T. Theory-driven evaluation: conceptual framework, application and advancement. In: Strobl RLO, Heitmeyer W, editors. Evaluation von Programmen und Projekten für eine demokratische Kultur. Wiesbaden: Springer; 2012. p. 17–40.CrossRef
  35.Sharpe G. A review of program theory and theory-based evaluations. American International J Contemp Res. 2011;3:72–5.
  36.Coryn CLS, Noakes LA, Westine CD, Schröter DC. A systematic review of theory-driven evaluation practice from 1990 to 2009. Am J Eval. 2011;32:199–226.CrossRef
  37.Donaldson SI, Lipsey MW. Roles for theory in contemporary evaluation practice: developing practical knowledge. In: Shaw IF, Greene JC, Mark MM, editors. The SAGE handbook of evaluation: policies, programs, and practices. London: Sage; 2006. p. 56–75.
  38.Guest G, MacQueen K, Namey EI. Introduction to applied thematic analysis, applied thematic analysis. http://​www.​sagepub.​com/​sites/​default/​files/​upm-binaries/​44134_​1.​pdf . 2012. Sage Publications Inc. Accessed 20 Jan 2016
  39.Carapetis JR. END RHD CRE (Centre for Research Excellence). 2015. http://​www.​rhdaustralia.​org.​au/​research . Accessed 20 Jan 2016
  
• 作者单位：Anna P. Ralph (1)
  Clancy Read (2)
  Vanessa Johnston (1)
  Jessica L. de Dassel (1)
  Kerstin Bycroft (1)
  Alice Mitchell (3)
  Ross S. Bailie (1)
  Graeme P. Maguire (4)
  Keith Edwards (5)
  Bart J. Currie (1)
  Adrienne Kirby (6)
  Jonathan R. Carapetis (2)
  
  1. Menzies School of Health Research, Darwin, NT, Australia
  2. Telethon Kids Institute, University of Western Australia, and Princess Margaret Hospital for Children, Perth, WA, Australia
  3. Charles Darwin University, Darwin, NT, Australia
  4. Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia
  5. Paediatric Department, Royal Darwin Hospital, Darwin, NT, Australia
  6. National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia
  
• 刊物主题：Medicine/Public Health, general; Biomedicine general; Statistics for Life Sciences, Medicine, Health Sciences;
• 出版者：BioMed Central
• ISSN：1745-6215

文摘

Background Rheumatic heart disease (RHD), caused by acute rheumatic fever (ARF), is a major health problem in Australian Aboriginal communities. Progress in controlling RHD requires improvements in the delivery of secondary prophylaxis, which comprises regular, long-term injections of penicillin for people with ARF/RHD.